semaglutide vs tirzepatide efficacy weight loss Compared Weight Loss Dynamics and Health
Description
More impressively, 83.5% of semaglutide-treated patients achieved at least 5% weight loss, while 66.1% reached 10% weight loss, and 50.5% achieved 15% or greater weight reduction

Participants were excluded from the trial if any of the following criteria applied: Glycemia-related HbA 1c 48 mmol mol 1 (6.5%) as measured by the central laboratory at screening

Weight loss continues at a steady pace during month 3

ROCK-nmMyoII, notch and Neurog3 gene-dosage link epithelial morphogenesis with cell fate in the pancreatic endocrine-progenitor niche

But oral and injectable are not equivalent

None of these factors mean tirzepatide causes UTIs